Investment
Features
FeesSafety
Academy
More
Pluang+

Compare O'Reilly Automotive Inc. Common Stock (ORLY) vs Viatris Inc (VTRS) Price & Performance

O'Reilly Automotive Inc. Common StockTrade
Viatris IncTrade

Price performance (Past 24H)

Key statistics

O'Reilly Automotive Inc. Common Stock vs Viatris Inc — how do they compare? O'Reilly Automotive Inc. Common Stock trades at $85.91 (market cap $68.45B), while Viatris Inc trades at $17.4 (market cap $20.12B). The key difference: O'Reilly Automotive Inc. Common Stock is far larger — about 3.4× Viatris Inc's market cap, and Viatris Inc pays a 2.74% dividend while O'Reilly Automotive Inc. Common Stock pays none. Which is the better fit depends on your goals.

ORLYVTRS
Market Cap
$68.45B$20.12B
Volume
6,667,5307,543,511
Sector
Consumer CyclicalHealth
52-Week High
$103.05$18.27
52-Week Low
$82.73$9.74
Enterprise Value
$77.77B$32.24B
Typical Hold Time
—57 Days
Dividend Yield
—2.74%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

O'Reilly Automotive Inc. Common Stock

No Aura AI signal available yet.

Viatris Inc

Viatris (VTRS) trades at $17.44, down 0.57% on the day, with a bullish technical signal from moving averages and oversold RSI levels. The company has beaten earnings estimates for three consecutive quarters, with Q2 2026 EPS of $0.69 exceeding expectations. Revenue trends show a slight decline from $16.3B in 2022 to $14.3B in 2025, but net losses have widened significantly, reaching -$3.51B in 2025. Positive cash flow generation and a dividend payment scheduled for September 2026 highlight financial stability amid profitability challenges.

The outlook for VTRS is mixed; analyst consensus is a 'Buy' with a $22.17 price target, implying 27% upside, supported by strong cash flow and recent product approvals. However, persistent net losses, high P/E ratio of 236.2, and substantial long-term debt of $14.04B pose risks. Investors should weigh the potential for operational turnaround against ongoing profitability concerns and competitive pressures in the healthcare sector.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About O'Reilly Automotive Inc. Common Stock

O'Reilly Automotive sells automotive aftermarket parts, tools, supplies, equipment, and accessories. It serves both professional service providers and do-it-yourself customers through its store network.

Read more on ORLY →

About Viatris Inc

Formed by the combination of Mylan and Pfizer's Upjohn business in 2020, Viatris is one of the world's largest generic drug manufacturers, with a substantial off-patent branded drug portfolio. Its portfolio consists of more than 1,400 molecules with penetration across most of the developed world and in select emerging markets. The company's branded drug portfolio consists of off-patent blockbuster drugs that continue to generate strong sales, including Lipitor, Norvasc, Lyrica, Viagra, and EpiPen. While global competition has facilitated the commodification of small-molecule generic drugs, the company has demonstrated an edge over peers in its ability to manufacture complex generics (for example, generic Advair and Copaxone).

Read more on VTRS →